-
DERMATOMYOSITIS MANAGEMENT IN GERMANY: A RETROSPECTIVE CLAIMS DATA ANALYSIS OF TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS
Aug 11, 2026, 17:16 PM -
HETEROGENEITY IN STATED PREFERENCES FOR COVID-19 PREP/PEP AMONG US ADULTS: A DISCRETE CHOICE EXPERIMENT WITH LATENT CLASS AND SUB-GROUP ANALYSES
Aug 11, 2026, 17:16 PM -
ECONOMIC AND HUMANISTIC BURDEN OF DISTANT METASTASIS IN EARLY-STAGE MELANOMA: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
CLOSING MENTAL HEALTH TREATMENT DESERTS: WHY MEDICAID RATE INCREASES ALONE FALL SHORT AND WHICH POLICIES EXPAND ACCESS
Aug 11, 2026, 17:16 PM -
FROM EMA AUTHORIZATION TO REIMBURSEMENT ACCESS: A CROSS-NATIONAL ANALYSIS OF MARKET ACCESS GAPS ACROSS FIVE EUROPEAN MARKETS (2021-2026)
Aug 11, 2026, 17:16 PM -
CLINICAL AND ECONOMIC IMPACT OF AN OPTIMIZED MESALAZINE-BASED MANAGEMENT STRATEGY VERSUS CURRENT STANDARD CARE IN PATIENTS WITH MILD-TO-MODERATE LEFT-SIDED ULCERATIVE COLITIS IN THE NETHERLANDS: A COST-OFFSET ANALYSIS
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE AND HEALTH-STATE UTILITIES IN IGA NEPHROPATHY: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
OPERATIONALISING VALUE-BASED PRICING FOR ADVANCED THERAPY MEDICINAL PRODUCTS IN BRAZIL: A MULTI-STAKEHOLDER WORKSHOP INFORMING THE REVISION OF THE NATIONAL DRUG PRICING FRAMEWORK
Aug 11, 2026, 17:16 PM -
TRANSARTERIAL PERIARTICULAR EMBOLIZATION (TAPE) AS A MINIMALLY INVASIVE AMBULATORY CARE STRATEGY TO OPTIMISE HEALTHCARE EXPENDITURE IN ADVANCED KNEE OSTEOARTHRITIS TREATMENT
Aug 11, 2026, 17:16 PM -
CLARITY THROUGH CONTRAST: ELEVATING STAKEHOLDER INSIGHTS FROM EDELPHI METHODS WITH A PATIENT-CENTERED MULTI-PANEL DESIGN
Aug 11, 2026, 17:16 PM -
INDIRECT TREATMENT COMPARISON OF ORFORGLIPRON AND ORAL SEMAGLUTIDE IN JAPANESE PATIENTS WITH TYPE 2 DIABETES
Aug 11, 2026, 17:16 PM -
TYPE 2 DIABETES AND FRACTURE RISK IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN: A CHINESE COHORT STUDY
Aug 11, 2026, 17:16 PM -
METHODOLOGICAL RESERVATIONS IN RECENT FRENCH CEESP ECONOMIC OPINIONS: WHAT CHARACTERISES THE MOST CHALLENGING SUBMISSIONS
Aug 11, 2026, 17:16 PM -
RECAST-DEMENTIA: A REGISTER-BASED ECONOMIC COST AND SEQUENCE TRANSFORMER FOR DEMENTIA CARE COST FORECASTING USING SWEDISH REGISTER DATA
Aug 11, 2026, 17:16 PM -
HETEROGENEITY IN "ACTIVE" CUTANEOUS LUPUS DEFINITIONS: IMPLICATIONS FOR TRIAL COMPARABILITY
Aug 11, 2026, 17:16 PM -
QUANTIFYING THE SOCIETAL VALUE OF A BREAST CANCER MEDICINES DONATION PROGRAM IN GHANA
Aug 11, 2026, 17:16 PM -
ADVANCING THE ASSESSMENT OF DIGITAL HEALTH INNOVATION - LESSONS DRAWN FROM A CATALOGUE OF AI USE CASES
Aug 11, 2026, 17:16 PM -
COMPARING THE PSYCHOMETRIC PERFORMANCE OF FOUR FATIGUE-RELATED EQ-5D-5L BOLT-ONS IN A MULTINATIONAL, LONGITUDINAL GENERAL POPULATION SETTING
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF CYP3A5 GENOTYPE-GUIDED TACROLIMUS DOSING IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A MONTE CARLO SIMULATION FROM AN INDIAN HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
BRIDGING THE GAP FROM SURROGATE TO HARD OUTCOMES IN C3 GLOMERULOPATHY: A BAYESIAN SURVIVAL MODELING FRAMEWORK TO PREDICT THE LONG-TERM IMPACT OF IPTACOPAN ON END-STAGE RENAL DISEASE (ESRD) FREE SURVIVAL
Aug 11, 2026, 17:16 PM
